{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidkcy55risaloavm4evvkqqr2457q7biz46we5yrrnh4tthdv2cqy",
    "uri": "at://did:plc:qx6osz4eyjjlnxy54n65xgxk/app.bsky.feed.post/3mii5ngnjccf2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreignb6gwnjsbx4hzuzgevn4owwm7edyttjwb7rwsoyg3nolivs7eei"
    },
    "mimeType": "image/jpeg",
    "size": 244962
  },
  "path": "/news/beauty/eli-lilly-weight-loss-pill-us-approval/",
  "publishedAt": "2026-04-01T16:39:26.000Z",
  "site": "https://www.businessoffashion.com",
  "textContent": "Orforglipron, which will be sold under the brand name Foundayo, becomes the second GLP-1 weight-loss pill to enter the US market after Novo Nordisk’s tablet-form Wegovy launched in Jan. 2026.",
  "title": "Eli Lilly’s Weight-Loss Pill Wins FDA Approval"
}